Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis

Gastroenterology

Volumn 146, Issue 4, 2014, Pages 970-979.e6

  Corpechot, Christophe ^a,b   Gaouar, Farid ^a   El Naggar, Ahmed ^a   Kemgang, Astrid ^a,b   Wendum, Dominique ^a   Poupon, Raoul ^a,b   Carrat, Fabrice ^a   Chazouillères, Olivier ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSERM   (France)

Author keywords

FibroScan; Prognosis; Surrogate Marker; Survival

Indexed keywords

ASPARTATE AMINOTRANSFERASE; HYALURONIC ACID; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; AREA UNDER THE CURVE; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE PLATELET RATIO INDEX SCORE; BILE DUCT CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGESTIVE DIAGNOSTIC DEVICE; DISEASE ASSOCIATION; DISEASE SEVERITY; ELASTOGRAPH; ELASTOGRAPHY; FEMALE; FIB 4 SCORE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FIBROSIS; LIVER HEMORRHAGE; LIVER STIFFNESS MEASUREMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MAYO RISK SCORE; MEASUREMENT; MIDDLE AGED; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; STAGING; THROMBOCYTE COUNT; VIBRATION CONTROLLED TRANSIENT ELASTOGRAPHY; YOUNG ADULT;

FIBROSCAN; PROGNOSIS; SURROGATE MARKER; SURVIVAL;

ADOLESCENT; AGED; BIOPSY; CHOLANGITIS, SCLEROSING; DISEASE PROGRESSION; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; LINEAR MODELS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84896448739     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.12.030     Document Type: Article

References (27)

1. G.M. Hirschfield, T.H. Karlsen, and K.D. Lindor et al. Primary sclerosing cholangitis Lancet 382 2013 1587 1599
2. R.H. Wiesner, P.M. Grambsch, and E.R. Dickson et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis Hepatology 10 1989 430 436
3. J.M. Farrant, K.M. Hayllar, and M.L. Wilkinson et al. Natural history and prognostic variables in primary sclerosing cholangitis Gastroenterology 100 1991 1710 1717
4. C.Y. Ponsioen, S.M. Vrouenraets, and W. Prawirodirdjo et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population Gut 51 2002 562 566
5. A. Garioud, P. Seksik, and Y. Chretien et al. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study Eur J Gastroenterol Hepatol 22 2010 842 847
6. W.R. Kim, T.M. Therneau, and R.H. Wiesner et al. A revised natural history model for primary sclerosing cholangitis Mayo Clin Proc 75 2000 688 694
7. A. Ruiz, S. Lemoinne, and F. Carrat et al. Radiologic course of primary sclerosing cholangitis: Assessment by 3D- magnetic resonance cholangiography and predictive features of progression Hepatology 59 2014 242 250
8. D.C. Rockey Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography Gastroenterology 134 2008 8 14
9. J.A. Talwalkar, D.M. Kurtz, and S.J. Schoenleber et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis Clin Gastroenterol Hepatol 5 2007 1214 1220
10. A. Berzigotti, S. Seijo, and U. Arena et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis Gastroenterology 144 2013 102 111 e1
11. J. Vergniol, J. Foucher, and E. Terrebonne et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C Gastroenterology 140 2011 1970 1979 1979 e1-3
12. S. Singh, L.L. Fujii, and M.H. Murad et al. Liver stiffness measurements are associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis Clin Gastroenterol Hepatol 11 2013 1573 1584
13. C. Corpechot, A. El Naggar, and A. Poujol-Robert et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC Hepatology 43 2006 1118 1124
14. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289 293
15. L. Sandrin, B. Fourquet, and J.M. Hasquenoph et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis Ultrasound Med Biol 29 2003 1705 1713
16. A. Vallet-Pichard, V. Mallet, and B. Nalpas et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest Hepatology 46 2007 32 36
17. M. Fraquelli, C. Rigamonti, and G. Casazza et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease Gut 56 2007 968 973
18. C. Corpechot, F. Carrat, and A. Poujol-Robert et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis Hepatology 56 2012 198 208
19. J. Foucher, E. Chanteloup, and J. Vergniol et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study Gut 55 2006 403 408
20. L. Castera, B. Le Bail, and F. Roudot-Thoraval et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores J Hepatol 50 2009 59 68
21. S. Al Mamari, J. Djordjevic, and J.S. Halliday et al. Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis J Hepatol 58 2013 329 334
22. G. Millonig, F.M. Reimann, and S. Friedrich et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis Hepatology 48 2008 1718 1723
23. P.J. Scheuer Ludwig Symposium on biliary disorders - part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis Mayo Clin Proc 73 1998 179 183
24. T.M. Mak, Y.P. Huang, and Y.P. Zheng Liver fibrosis assessment using transient elastography guided with real-time B-mode ultrasound imaging: a feasibility study Ultrasound Med Biol 39 2013 956 966
25. P. Angulo, D.R. Larson, and T.M. Therneau et al. Time course of histological progression in primary sclerosing cholangitis Am J Gastroenterol 94 1999 3310 3313
26. K.D. Lindor, K.V. Kowdley, and V.A. Luketic et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis Hepatology 50 2009 808 814
27. R. Olsson, K.M. Boberg, and O.S. de Muckadell et al. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study Gastroenterology 129 2005 1464 1472